2m 2m 2m 2m 2m 2m 2m
ASTRAZENECA (AZN)
NYSE
$180.04+$3.60 (+2.04%)
Price as of Jun 23, 2026 12:40 PM EDT- $273.6BMarket Cap
- 154.11%1-Year Change
- Drug Manufacturers - GeneralIndustry
ASTRAZENECA (AZN)
$180.04+$3.60 (+2.04%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 0 -100.00% | 54.1B +18.03% | 45.8B +3.29% | 44.4B +18.53% | |
Cost of Revenue | 10.6B +4.17% | 10.2B +23.45% | 8.3B -33.27% | 12.4B -0.37% | |
Gross Profit | -138.0M -100.31% | 43.9B +16.84% | 37.5B +17.47% | 32.0B +27.94% | |
Sales and Marketing Expense | 19.9B -0.22% | 20.0B +3.96% | 19.2B +4.33% | 18.4B +20.91% | |
Research and Development Expense | -14.2B +4.78% | -13.6B +24.22% | -10.9B +12.02% | -9.8B +0.27% | |
Depreciation and Amortization Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Operating Expenses | 19.9B -0.22% | 20.0B +3.96% | 19.2B +4.33% | 18.4B +20.91% | |
Operating Profit | 13.7B +37.39% | 10.0B +22.09% | 8.2B +118.07% | 3.8B +255.78% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Income before Taxes | 10.2B +45.33% | 7.0B +18.12% | 6.0B +81.02% | 3.3B +2,763.48% | |
Income Taxes | 2.2B +31.45% | 1.6B +75.91% | 938.0M +218.43% | -792.0M +108.42% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 10.2B +45.33% | 7.0B +18.12% | 6.0B +81.02% | 3.3B +2,763.48% | |
Net Income from Continuing Operations Applicable to Common | 10.2B +45.33% | 7.0B +18.12% | 6.0B +81.02% | 3.3B +2,763.48% | |
Basic EPS and Net Income | 6.60 +45.37% | 4.54 +18.23% | 3.84 +81.13% | 2.12 +2,550.00% | |
Diluted EPS and Net Income | 6.54 +45.33% | 4.50 +18.11% | 3.81 +80.57% | 2.11 +2,537.50% | |
Basic Weighted Average Shares | 1.6B 0.00% | 1.6B +0.06% | 1.5B +0.06% | 1.5B +9.17% | |
Diluted Weighted Average Shares | 1.6B 0.00% | 1.6B +0.06% | 1.5B +0.06% | 1.5B +9.17% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 5.7B +4.06% | 5.5B -6.03% | 5.8B -5.29% | 6.2B -2.58% | |
Short-Term Investments | 30.0M -81.93% | 166.0M +36.07% | 122.0M -48.95% | 239.0M +246.38% | |
Cash and Cash Equivalents and Short-Term Investments | 5.7B +1.54% | 5.7B -5.17% | 6.0B -6.92% | 6.4B +0.11% | |
Total Current Assets | 28.7B +11.21% | 25.8B +3.09% | 25.1B +10.89% | 22.6B -13.91% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 13.0B +26.43% | 10.3B +9.04% | 9.4B +10.52% | 8.5B -7.36% | |
Total Long-Term Assets | 85.4B +9.13% | 78.2B +2.82% | 76.1B +2.94% | 73.9B -6.61% | |
Total Assets | 114.1B +9.65% | 104.0B +2.88% | 101.1B +4.80% | 96.5B -8.43% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 30.6B +9.87% | 27.9B -8.76% | 30.5B +16.16% | 26.3B +16.37% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 34.7B -1.59% | 35.3B +12.37% | 31.4B -5.19% | 33.1B -23.80% | |
Total Liabilities | 65.4B +3.47% | 63.2B +1.95% | 62.0B +4.25% | 59.4B -10.07% | |
Retained Earnings | 11.0B +247.22% | 3.2B +110.39% | 1.5B +361.67% | -574.0M -133.57% | |
Total Stockholders Equity | 48.7B +19.20% | 40.9B +4.35% | 39.2B +5.69% | 37.1B -5.67% | |
Total Shares Outstanding | 1.6B +0.02% | 1.6B +0.02% | 1.6B +0.02% | 1.5B +0.03% | |
Cash Flow | |||||
Cash from Operating Activities | 1.3B -88.90% | 11.9B +14.65% | 10.3B +5.48% | 9.8B +64.48% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -6.8B -14.69% | -8.0B +96.36% | -4.1B +37.30% | -3.0B -73.23% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -7.5B +88.79% | -4.0B -39.15% | -6.6B -3.75% | -6.8B -286.98% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | 81.12% -1.01% | 81.95% +13.72% | 72.06% +7.94% | |
Operating Margin | N/A N/A | 18.50% +3.44% | 17.88% +111.12% | 8.47% +200.16% | |
Return on Assets | 9.38% +36.70% | 6.86% +13.77% | 6.03% +84.91% | 3.26% +2,342.29% | |
Return on Equity | 22.84% +29.84% | 17.59% +12.49% | 15.64% +81.31% | 8.63% +1,959.84% | |
Revenue Growth | -100.00% -654.48% | 18.04% +447.86% | 3.29% -82.24% | 18.53% -54.33% | |
Current Ratio | 0.94 +1.22% | 0.93 +12.98% | 0.82 -4.54% | 0.86 -26.02% | |
Cash Ratio | 0.19 -5.28% | 0.20 +2.98% | 0.19 -18.46% | 0.23 -16.28% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow